B.O'Mahony^1,2; J. Mahlangu³; K.Peerlinck⁴; JDWang⁵; G. Lowe⁶; CWTan⁷; A. Giermasz⁸; H.Tran⁹; TLKhoo¹⁰; E. Cockrell¹¹; D. Pepperell¹²; H.Chambost¹³; MFLFernández¹⁴; R.Kazmi¹⁵; E.Majerus¹⁶; MWSkinner^17,18; R.Klamroth¹⁹; J. Quinn²⁰; H.Yu²⁰; WYWong²⁰; A.Lawal²⁰; TMRobinson²⁰; B.Kim²⁰

¹Irish Haemophilia Society;²Trinity College, Dublin, Irland;³ Hemophilia Comprehensive Care Center, Charlotte Maxeke Johannesburg Academic Hospital, University of the Witwatersrand og NHLS, Johannesburg, Sydafrika;⁴ Institut for Vaskulær Medicin og Hæmostase og Hæmofili Center, Universitetshospitalerne Leuven, Leuven, Belgien;⁵ Center for sjældne sygdomme og hæmofili, Taichung Veterans General Hospital, Taichung, Taiwan, provinsen Kina;⁶ West Midlands Comprehensive Care Haemophilia Centre, Queen Elizabeth Hospital, Birmingham, Storbritannien;⁷ Hæmatologisk afdeling, Royal Adelaide Hospital, Adelaide, Australien;⁸ Hemophilia Treatment Center, University of California Davis, Sacramento, USA;⁹ Hæmostase og tromboseenhed, Haemophilia Treatment Centre, The Alfred Hospital, Melbourne;¹⁰ Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, Australien;¹¹ Pædiatrisk hæmatologisk onkologi, Saint Joseph's Children's Hospital, Tampa, USA;¹² Hæmatologisk afdeling, Fiona Stanley Hospital, Murdoch, Australien;¹³ AP-HM, afdelingen for pædiatrisk hæmatologisk onkologi, børnehospitalet La Timone, Aix Marseille Universitet, INSERM, INRA, C2VN, Marseille, Frankrig;¹⁴ Complejo Hospitalario Universitario A Coruña, A Coruña, Spanien;¹⁵ Department of Haematology, Southampton University Hospital, Southampton, Storbritannien;¹⁶ Institut for Medicin, Washington University i St. Louis, St. Louis;¹⁷ Institute for Policy Advancement Ltd, Washington, USA;¹⁸ McMaster University, Hamilton, Canada;¹⁹ Comprehensive Care Haemophilia Treatment Center, Vivantes Klinikumim Friedrichshain, Berlin, Tyskland;²⁰ BioMarin Pharmaceutical Inc., Novato, USA